I keep looking at the Wilson's broker report that you kindly shared with the forum. They had VP-001 valued at 10c per share due to its early positive results for safety and efficacy.
Based on PYC's estimation of potential market size for PYC-001 and PYC-003, in 12 to 18 months time, and assuming we get similar safety and early efficacy data to that of VP-001 (and everything else being equal), we are looking at valuations for PYC-001 and PYC-003 of 20c and $1, respectively.
Reality says were only about half the 37c valuation of the Wilson Report, so to imagine we'd have a MC of around $6B in 12 to 18 months is probably stretching things too far but a MC of $3B by Xmas 2025 doesn't seem beyond the realms of possibility.
A dilution will be painful for those that don't have the cash to participate or if us retail investors are excluded like we were the raise before last. But the future is bright if you can afford to hold for another 5 years.
PYC Price at posting:
18.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)